- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17:46 | Lilly's 'triple-G' drug tops Novo's Ozempic in diabetes trial | ||
| 16:46 | FDA unveils guidance for 'plug and play' gene therapies | ||
| 15:46 | Lilly shuffles business structure; Novartis writes off part of Avidity deal | ||
| Di | Ferring to acquire next-gen IVF startup Gameto for up to $1.4B | ||
| Di | Court rejects Novo bid to block Lilly obesity drug ads | ||
| Di | Artiva to quit autoimmune cell therapy work, cut staff after patient deaths | ||
| Mo | Corxel, an obesity drugmaker, to go public via SPAC deal | ||
| Mo | BioNTech, DualityBio say ADC had 'modest' benefit in breast cancer study | ||
| Mo | ESMO '26: A cancer vaccine debate, Roche's KRAS progress and Amgen's 'unprecedented' data | ||
| Mo | Another autoimmune CAR-T death; Treasury zeroes in on China deals | ||
| Mo | The molecule was fine. The moment wasn't. | ||
| Mo | Novel protein and peptide therapeutics | ||
| Fr | This week in charts: a big year for RNAi developers | ||
| Fr | Star adds $200M after spinout successes | ||
| Do | Moderna, Merck shares fall on eagerly anticipated cancer vaccine results | ||
| Do | Biohaven's previously rejected rare disease drug to get fresh FDA review | ||
| Do | GLP-1 compounder issues recall for copycat Zepbound | ||
| Do | Roche affirms sales outlook amid doubts about its future | ||
| 21.10. | GSK, Ionis win US approval for first-of-its-kind hepatitis B drug | ||
| 21.10. | Roivant, continuing ascent, claims another victory for rare disease drug | ||
| 21.10. | Arcus kidney cancer data impresses analysts; TriGemX inks a SPAC deal | ||
| 20.10. | Rapport's epilepsy drug finds surprising success in bipolar trial | ||
| 20.10. | Most new drugs are still too costly at launch, ICER says | ||
| 20.10. | Hype vs. reality: What pharma's hottest R&D bets have actually proved | ||
| 19.10. | Disc's once-spurned rare disease drug to get a second chance at approval |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.